NOTE: This disposition is nonprecedential. United States Court of Appeals
for the Federal Circuit
ABBVIE BIOTECHNOLOGY, LTD.,
Appellant
v.
UNITED STATES, ANDREI IANCU, UNDER
SECRETARY OF COMMERCE FOR
INTELLECTUAL PROPERTY AND DIRECTOR OF THE UNITED STATES PATENT AND TRADEMARK
OFFICE,
Intervenors
2017-2304, 2017-2305, 2017-2306, 2017-2362, 2017-2363
Appeals from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR2016-00172, IPR2016-00188, IPR2016-00189, IPR2016-00408, IPR2016-00409.
JUDGMENT
THOMAS SAUNDERS, Wilmer Cutler Pickering Hale and Dorr LLP, Washington, DC, argued for appellant. Also represented by WILLIAM G. MCELWAIN, AMY K. WIGMORE, DAVID P. YIN; WILLIAM F. LEE, Boston, MA; WILLIAM
2BARRETT RAICH, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington, DC; CHARLES E. LIPSEY, STEVEN O'CONNOR, Reston, VA. NICHOLAS THEODORE MATICH, IV, Office of the Solicitor, United States Patent and Trademark Office, Alexandria, VA, argued for intervenors. Also represented by THOMAS W. KRAUSE, JOSEPH MATAL, MEREDITH HOPE SCHOENFELD, KAKOLI CAPRIHAN; DENNIS FAN, JOSEPH H. HUNT, SCOTT R. MCINTOSH, Appellate Staff, Civil Division, United States Department of Justice, Washington, DC.
THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:
Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
January 7, 2020 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court